The cost of lung cancer in Turkey

E. Cakir, C. Karlikaya (Edirne, Turkey)

Source: Annual Congress 2004 - Chemotherapy, targeted therapies costs and outcomes
Session: Chemotherapy, targeted therapies costs and outcomes
Session type: Thematic Poster Session
Number: 1950
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Cakir, C. Karlikaya (Edirne, Turkey). The cost of lung cancer in Turkey. Eur Respir J 2004; 24: Suppl. 48, 1950

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interval change in prevalence and survival from lung cancer in the west of Ireland
Source: Annual Congress 2006 - Lung cancer staging and miscellaneous
Year: 2006


Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Direct medical costs of lung cancer in Oran hospital
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007

Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008


The feasibility of a lung cancer screening program in rural Ireland
Source: Eur Respir J 2006; 28: Suppl. 50, 80s
Year: 2006

Initial symptoms and diagnostic delays of lung cancer in southern Norway
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006

Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006


Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Characteristics of lung cancer patients in Serbia and subsequent treatment in advanced NSCLC over time – epidemiology study
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

The changing epidemiological trends for carcinoma of the lung in Turkey
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008


Our diagnostic time for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 322s
Year: 2005

Lung cancer and TB incidence evolution in Portugal
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018

The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007